Chemed Corp (CHE)
Healthcare
Medical Care Facilities
532.30 $
-0.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Chemed Corp (CHE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.4% of the shares are freely tradable; institutional investors hold 104.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
104.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
96.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
13Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.07 | 1,336,690 | +4.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 6.15 | 815,699 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.79 | 636,070 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 3.77 | 500,987 | -4.0 | 03/31/2026 |
| State Street Corp | 3.48 | 462,170 | +0.9 | 03/31/2026 |
| AQR Capital Management LLC | 3.13 | 415,612 | +27.7 | 03/31/2026 |
| Geode Capital Management, LLC | 3.10 | 411,046 | +14.8 | 03/31/2026 |
| Van Berkom and Associates Inc | 2.49 | 330,176 | +88.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.42 | 454,175 | +0.2 | 07/28/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.21 | 426,111 | -5.5 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.